These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

637 related articles for article (PubMed ID: 31983023)

  • 21. Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents.
    Brigo F; Igwe SC
    Cochrane Database Syst Rev; 2017 Feb; 2(2):CD003032. PubMed ID: 28195639
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Levetiracetam as add-on therapy in generalised epilepsies.
    Kumar SP; Smith PE
    Seizure; 2004 Oct; 13(7):475-7. PubMed ID: 15324824
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Withholding the choice of sodium valproate to young women with generalised epilepsy: Are we causing more harm than good?
    Mole TB; Appleton R; Marson A
    Seizure; 2015 Jan; 24():127-30. PubMed ID: 25223837
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epilepsy treatment in adults and adolescents: Expert opinion, 2016.
    Shih JJ; Whitlock JB; Chimato N; Vargas E; Karceski SC; Frank RD
    Epilepsy Behav; 2017 Apr; 69():186-222. PubMed ID: 28237319
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of typical absence seizures and related epileptic syndromes.
    Panayiotopoulos CP
    Paediatr Drugs; 2001; 3(5):379-403. PubMed ID: 11393330
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and tolerability of zonisamide in juvenile myoclonic epilepsy.
    Kothare SV; Valencia I; Khurana DS; Hardison H; Melvin JJ; Legido A
    Epileptic Disord; 2004 Dec; 6(4):267-70. PubMed ID: 15634623
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lamotrigine in absence and primary generalized epilepsies.
    Mikati MA; Holmes GL
    J Child Neurol; 1997 Nov; 12 Suppl 1():S29-37. PubMed ID: 9429128
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phenytoin versus valproate monotherapy for partial onset seizures and generalized onset tonic-clonic seizures.
    Tudur Smith C; Marson AG; Williamson PR
    Cochrane Database Syst Rev; 2001; (4):CD001769. PubMed ID: 11687121
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Update on pharmacotherapy of myoclonic seizures.
    Striano P; Belcastro V
    Expert Opin Pharmacother; 2017 Feb; 18(2):187-193. PubMed ID: 28067060
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alternatives to valproate in girls and women of childbearing potential with Idiopathic Generalized Epilepsies: state of the art and guidance for the clinician proposed by the Epilepsy and Gender Commission of the Italian League Against Epilepsy (LICE).
    Mostacci B; Ranzato F; Giuliano L; La Neve A; Aguglia U; Bilo L; Durante V; Ermio C; Monti G; Zambrelli E; Lodi MAM; Galimberti CA
    Seizure; 2021 Feb; 85():26-38. PubMed ID: 33418162
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Levetiracetam in the treatment of idiopathic generalized epilepsies.
    Grünewald R
    Epilepsia; 2005; 46 Suppl 9():154-60. PubMed ID: 16302890
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The first line of therapy in a girl with juvenile myoclonic epilepsy: should it be valproate or a new agent?
    Montouris G; Abou-Khalil B
    Epilepsia; 2009 Sep; 50 Suppl 8():16-20. PubMed ID: 19702728
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adjunctive brivaracetam - A prospective audit of outcomes from an epilepsy clinic.
    Stephen L; Brodie MJ
    Epilepsy Behav; 2021 Mar; 116():107746. PubMed ID: 33517200
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selection of drugs for the treatment of epilepsy.
    Mattson RH
    Semin Neurol; 1990 Dec; 10(4):406-13. PubMed ID: 2287835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Myoclonus and epilepsy in childhood: a review of treatment with valproate, ethosuximide, lamotrigine and zonisamide.
    Wallace SJ
    Epilepsy Res; 1998 Jan; 29(2):147-54. PubMed ID: 9477147
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment outcomes in drug resistant juvenile myoclonic epilepsy: Valproate resistance may not be the end of the road.
    Baheti N; Rathore C; Bansal AR; Shah S; Veedu HK; Prakash S; Kanhere K; Jaiswal SK; Jukkarwala A; Murthy JMK; Radhakrishnan K
    Seizure; 2021 Nov; 92():112-117. PubMed ID: 34496330
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Perampanel in routine clinical use in idiopathic generalized epilepsy: The 12-month GENERAL study.
    Villanueva V; Montoya J; Castillo A; Mauri-Llerda JÁ; Giner P; López-González FJ; Piera A; Villanueva-Hernández P; Bertol V; Garcia-Escrivá A; Garcia-Peñas JJ; Garamendi I; Esteve-Belloch P; Baiges-Octavio JJ; Miró J; Falip M; Garcés M; Gómez A; Gil-López FJ; Carreño M; Rodriguez-Uranga JJ; Campos D; Bonet M; Querol R; Molins A; Tortosa D; Salas-Puig J
    Epilepsia; 2018 Sep; 59(9):1740-1752. PubMed ID: 30062784
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment options in juvenile myoclonic epilepsy.
    Mantoan L; Walker M
    Curr Treat Options Neurol; 2011 Aug; 13(4):355-70. PubMed ID: 21494841
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review.
    Nevitt SJ; Marson AG; Tudur Smith C
    Cochrane Database Syst Rev; 2019 Jul; 7(7):CD001911. PubMed ID: 31318037
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of topiramate in childhood generalized seizure disorders.
    Wheless JW
    J Child Neurol; 2000; 15 Suppl 1():S7-13. PubMed ID: 11218056
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.